Evaluation of the Performance of the Loopamp Trypanosoma cruzi Detection Kit for the Diagnosis of Chagas Disease in an Area Where It Is Not Endemic, Spain
dc.contributor.author
dc.date.accessioned
2022-04-27T08:50:26Z
dc.date.available
2022-04-27T08:50:26Z
dc.date.issued
2021-04-20
dc.identifier.issn
0095-1137
dc.identifier.uri
dc.description.abstract
In Spain, PCR is the tool of choice for the diagnosis of congenital Chagas disease (CD) and serology for diagnosing chronic CD. A loop-mediated isothermal amplification test for Trypanosoma cruzi DNA detection showed good analytical performance and ease of use. We aimed to evaluate the performance of the Loopamp Trypanosoma cruzi detection kit (Eiken Chemical Co. Ltd., Japan) (Tcruzi-LAMP) for congenital and chronic CD diagnosis using well-characterized samples. We included samples from 39 congenital and 174 chronic CD cases and from 48 uninfected children born to infected mothers and 34 nonchagasic individuals. The sensitivity, specificity, and accuracy of Tcruzi-LAMP were estimated using standard case definitions for congenital CD (positive result by parasitological or PCR tests or serology after 9 months of age) and chronic CD (positive serology by at least two tests). The Tcruzi-LAMP results were read by visual examination and a real-time fluorimeter. For congenital CD, Tcruzi-LAMP sensitivity was 97% for both types of reading; specificity was 92% by visual examination and 94% by fluorimeter. For chronic CD, sensitivity was 47% and specificity 100%. The accuracy in congenital CD was >94% versus 56% in chronic CD. The agreement of Tcruzi-LAMP with PCR tests was better in congenital CD (kappa, 0.86 to 0.91) than in chronic CD (kappa, 0.67 to 0.83). The Loopamp Trypanosoma cruzi detection kit showed good performance for the diagnosis of congenital CD. Tcruzi-LAMP, like PCR, can be useful for the screening and early diagnosis of congenital infection
dc.description.sponsorship
This research was supported by the Foundation for Innovative New Diagnostics
(FIND), Geneva, Switzerland (WO klob-0003), and the Surveillance Program of Chagas
Disease of the National Centre for Microbiology, Instituto de Salud Carlos III. The CNM
and ISGlobal teams are part of the Tropical Disease Cooperative Research Network (RICET) (RD12/0018/0010). The ISGlobal research team is supported by the Agència de
Gestió d’Ajuts Universitaris i de Recerca (AGAUR) (2017 SGR 00924). ISGlobal is a
member of the Centres de Recerca de Catalunya (CERCA) Programme, Government of
Catalonia, Spain. FIND is grateful to its donors
dc.format.mimetype
application/pdf
dc.language.iso
eng
dc.publisher
American Society for Microbiology
dc.relation.isformatof
Reproducció digital del document publicat a: https://doi.org/10.1128/JCM.01860-20
dc.relation.ispartof
Journal of Clinical Microbiology, vol. 59, núm. 5, p. e01860-20
dc.relation.ispartofseries
Articles publicats (D-B)
dc.rights
Attribution 4.0 International
dc.rights.uri
dc.subject
dc.title
Evaluation of the Performance of the Loopamp Trypanosoma cruzi Detection Kit for the Diagnosis of Chagas Disease in an Area Where It Is Not Endemic, Spain
dc.type
info:eu-repo/semantics/article
dc.rights.accessRights
info:eu-repo/semantics/openAccess
dc.type.version
info:eu-repo/semantics/publishedVersion
dc.identifier.doi
dc.identifier.idgrec
033837
dc.type.peerreviewed
peer-reviewed
dc.identifier.eissn
1098-660X